D. Nathwani

11 papers receiving 580 citations

Peers

D. Nathwani
Comparison fields: 5 of 70
  • Infectious Diseases 220
  • Epidemiology 216
  • Critical Care and Intensive Care Medicine 194
  • Applied Microbiology and Biotechnology 147
  • Clinical Biochemistry 139
Replace Maciej Piotr Chlebicki with:
Maciej Piotr Chlebicki Singapore
Jeannie D. Chan United States
Carole Fry United Kingdom
S. Harbarth Switzerland
Ed Casabar United States
Russell T. Attridge United States
Fidelma A. Magee United Kingdom
Klaus Weist Germany
M. Ricart Spain
David X. Li United States
D. Nathwani relative to Maciej Piotr Chlebicki Singapore Maciej Piotr Chlebicki's profile →
Citations per field
00.5×1.5×
Maciej Piotr Chlebicki · 1×
Citations per year

Countries citing papers authored by D. Nathwani

Since Specialization
Citations

This map shows the geographic impact of D. Nathwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Nathwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Nathwani more than expected).

Fields of papers citing papers by D. Nathwani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Nathwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Nathwani. The network helps show where D. Nathwani may publish in the future.

Co-authorship network of co-authors of D. Nathwani

This figure shows the co-authorship network connecting the top 25 collaborators of D. Nathwani. A scholar is included among the top collaborators of D. Nathwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Nathwani. D. Nathwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 84
2 115
3 219
4 41
5 3
6 55
7 59
8 15
9
Uptake of influenza vaccination and the reasons for non-vaccination in the high-risk patients of Angus, Scotland.
1
10 1
11 13

About D. Nathwani

D. Nathwani is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Molecular Medicine, having authored 11 papers that have together received 606 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (147 citations), Critical Care and Intensive Care Medicine (194 citations) and Clinical Biochemistry (139 citations). D. Nathwani has collaborated with scholars based in United Kingdom, Israel and France. Frequent co-authors include Peter Davey, Joanne Cleverley, Mark H. Wilcox, M. K. Street, A. Gascoigne, Paul Dilworth, E. Brown, John R. Armstrong, A. Galloway and Alan J. Knox. Their work appears in journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026